Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 13, 2011
The management of neuroendocrine tumours: current and future medical therapy optionsK E ObergJournal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 1, 1997
Antibodies to interferon-alpha in treated cancer patients: incidence and significanceR M McKenna, K E ObergBailliere'S Clinical Gastroenterology|December 1, 1996
Carcinoid tumoursE M Tiensuu Janson, K E ObergAnnals of Internal Medicine|August 1, 1991
Autoimmunity after alpha-interferon therapy for malignant carcinoid tumorsL E Rönnblom, G V Alm, K E ObergJournal of Internal Medicine|March 1, 1990
Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumourL E Rönnblom, G V Alm, K E ObergHormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 1, 2011
Oncolytic viruses for the treatment of neuroendocrine tumorsM Essand, J Leja, V Giandomenico, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Octreotide and interferon alfa: a new combination for the treatment of malignant carcinoid tumoursE M Tiensuu Janson, H Ahlström, T Andersson, et al.Clinical and Experimental Immunology|September 1, 1992
Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatmentL E Rönnblom, E T Janson, A Perers, et al.Cancer|December 5, 1998
Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumorsB K Eriksson, E G Larsson, B M Skogseid, et al.Digestion|January 1, 1996
The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumoursB Eriksson, E T Janson, N D Bax, et al.Pageof 2